Takeda Announces Approval of CUVITRUâ„¢ Subcutaneous Immunoglobulin in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia
Approval is Based on Clinical Studies Conducted in Japan, Europe and North America Confirming the…
Approval is Based on Clinical Studies Conducted in Japan, Europe and North America Confirming the…
VANCOUVER, British Columbia--(BUSINESS WIRE)--Capstone Copper Corp. (“Capstone†or the “Companyâ€) (TSX:CS) is pleased to announce…
OIC Facility Brings Expected Capital Available in Connection with the Proposed Business Combination with Twin…
HEFEI, China--(BUSINESS WIRE)--Multinational corporations are an important force in building an open world economy. The…
VANCOUVER, British Columbia--(BUSINESS WIRE)--Pan American Silver Corp. (NYSE: PAAS) (TSX: PAAS) ("Pan American") has completed…
DUBLIN--(BUSINESS WIRE)--The "Adaptive Traffic Control System Market Forecast to 2030 - Global Analysis by Type,…
Subcutaneous EPKINLYâ„¢(epcoritamab) is the first and only bispecific antibody approved in Japan to treat adult…
Mandy becomes latest big winner at Australia’s favourite online casino SYDNEY--(BUSINESS WIRE)--Want big wins? Then…
PARIS--(BUSINESS WIRE)--Regulatory News: NHOA Energy, the company of NHOA Group (Paris:NHOA) dedicated to energy storage,…
Dragon’s Dogma 2 wins award in the Future Division OSAKA, Japan--(BUSINESS WIRE)--#Capcom--Capcom Co., Ltd. (TOKYO:9697)…